This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2012 Aug 21;157(4):JC2-2.

doi: 10.7326/0003-4819-157-4-201208210-02002.

ACP Journal Club: review: varenicline for tobacco cessation does not increase CV serious adverse events

Paul Krebs¹, Scott E Sherman

Affiliations

PMID: 22910956
DOI: 10.7326/0003-4819-157-4-201208210-02002

Comment

ACP Journal Club: review: varenicline for tobacco cessation does not increase CV serious adverse events

Paul Krebs et al. Ann Intern Med. 2012.

. 2012 Aug 21;157(4):JC2-2.

doi: 10.7326/0003-4819-157-4-201208210-02002.

Authors

Paul Krebs¹, Scott E Sherman

Affiliation

¹ VA New York Harbor Healthcare System, New York University School of Medicine, New York, New York, USA.

PMID: 22910956
DOI: 10.7326/0003-4819-157-4-201208210-02002

No abstract available

PubMed Disclaimer

Comment on

Risk of cardiovascular serious adverse events associated with varenicline use for tobacco cessation: systematic review and meta-analysis.
Prochaska JJ, Hilton JF. Prochaska JJ, et al. BMJ. 2012 May 4;344:e2856. doi: 10.1136/bmj.e2856. BMJ. 2012. PMID: 22563098 Free PMC article.

Publication types

Actions

LinkOut - more resources

Full Text Sources
- Atypon